Eye complications in type 2 diabetes mellitus
Bek, T.
Ugeskrift for Laeger 174(37): 2147-2150
2012
ISSN/ISBN: 1603-6824 PMID: 22971294 Document Number: 658587
Diabetic retinopathy frequently causes blindness, especially in patients with type 2 diabetes mellitus (T2D). The implementation of systematic screening can improve the visual prognosis significantly, and recently decision models that allow individualised determination of control intervals on the basis of known risk factors have been introduced. Current treatment of diabetic retinopathy with retinal photocoagulation has adverse effects with severe consequences for patients with T2D. However, recently intravitreal angiostatic therapy has been introduced as an effective new modality for the treatment of diabetic retinopathy.
Document emailed within 1 workday
Related Documents
Jongsareejit, A.; Potisat, S.; Krairittichai, U.; Sattaputh, C.; Arunratanachote, W. 2013: The Thai DMS Diabetes Complications (DD.Comp.) project: prevalence and risk factors of diabetic retinopathy in Thai patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 96(11): 1476-1482Dahiya, K.; Aggarwal, K.; Seth, S.; Singh, V.; Sharma, T.K. 2010: Type 2 Diabetes Mellitus Without Vascular Complications and Ischemia Modified Albumin Clinical Laboratory 56(5-6): 187-190
Ahamed, A.; Shantha, G.P.S.; Agarwal, G.; Senthil, N.; Paunikar, N.; Sudhakar, M.K. 2008: Prevalence of microvascular complications in metabolic syndrome in comparison to type 2 diabetes mellitus Journal of the Indian Medical Association 106(9): 583
Zhang, Q.; Li, Y.; Chen, L. 2015: Effect of berberine in treating type 2 diabetes mellitus and complications and its relevant mechanisms Zhongguo Zhong Yao Za Zhi 40(9): 1660-1665
Topuria, D.I. 2004: Natural and preformed physical factors in the treatment of late complications in diabetes mellitus type 2 Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 5: 20-22
Habán, P. 1997: Risk of cardiovascular complications in patients with type Ii diabetes mellitus in relation to serum triacylglycerols Bratislavske Lekarske Listy 98(3): 158-162
Sinha, S.; Guleria, R.; Misra, A.; Pandey, R.M.; Yadav, R.; Tiwari, S. 2004: Pulmonary functions in patients with type 2 diabetes mellitus and correlation with anthropometry and microvascular complications Indian Journal of Medical Research 119(2): 66-71
Kozek, E.; Górska, A.; Fross, K.; Marcinowska, A.; Citkowska, A.; Sieradzki, J. 2003: Chronic complications and risk factors in patients with type 1 diabetes mellitus--retrospective analysis Przeglad Lekarski 60(12): 773-777
Kishikawa, H.; Araki, E.; Wake, N.; Shichiri, M. 2002: Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus Nihon Rinsho. Japanese Journal of Clinical Medicine 60 Suppl. 9: 140-145
Belousova, L.N.; Izmaylova, O.A. 2017: Preventing complications of II type diabetes mellitus in workers of scientific and production center of nuclear industry Meditsina Truda i Promyshlennaia Ekologiia 2017(2): 45-48
Jain, S. 2020: Study of Serum Magnesium Level in Type 2 Diabetes Mellitus Patients with Special Emphasis on Microvascular Macrovascular Complications Journal of the Association of Physicians of India 68(1): 50
Mishra, T.K.; Rath, P.K.; Mohanty, N.K.; Mishra, S.K. 2008: Left ventricular systolic and diastolic dysfunction and their relationship with microvascular complications in normotensive, asymptomatic patients with type 2 diabetes mellitus Indian Heart Journal 60(6): 548-553
DZugkoev, S.G.; Zangieva, O.D.; Dzugkoeva, F.S. 2013: Influence of combined treatment on biochemical and functional characteristics in patients with vascular complications of type 1 diabetes mellitus and different pathways of compensation Klinicheskaia Meditsina 91(2): 14-18
Mwendwa, F.M.; Otieno, C.F.; Kayima, J.K.; Amayo, E.O.; Otieno, P.O. 2005: Risk factor profile and the occurrence of microvascular complications in short-term type 2 diabetes mellitus at Kenyatta National Hospital, Nairobi East African Medical Journal 82(12 Suppl): S163-S172
Likitmaskul, S.; Wacharasindhu, S.; Rawdaree, P.; Ngarmukos, C.; Deerochanawong, C.; Suwanwalaikorn, S.; Chetthakul, T.; Bunnag, P.; Kosachunhanun, N.; Plengvidhaya, N.; Leelawatana, R.; Krittiyawong, S.; Benjasuratwong, Y.; Pratipanawatr, T. 2006: Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes Journal of the Medical Association of Thailand 89(Suppl 1): S10-S16
Liebl, A.; Goertz, A.; Henkel, B.; Spannheimer, A. 2000: Costly type 2 diabetes mellitus. Does diabetes cost 20 billion per year? MMW Fortschritte der Medizin 142(23): 39-42
Chetthakul, T.; Likitmaskul, S.; Plengvidhya, N.; Suwanwalaikorn, S.; Kosachunhanun, N.; Deerochanawong, C.; Krittiyawong, S.; Leelawatana, R.; Benjasuratwong, Y.; Bunnag, P.; Prathipanawatr, T.; Ngarmukos, C.; Mongkolsomlit, S.; Rawdaree, P. 2006: Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus Journal of the Medical Association of Thailand 89(Suppl 1): S17-S26
Chetthakul, T.; Deerochanawong, C.; Suwanwalaikorn, S.; Kosachunhanun, N.; Ngarmukos, C.; Rawdaree, P.; Krittiyawong, S.; Leelawatana, R.; Bunnag, P.; Plengvidhya, N.; Pratipanawatr, T.; Benjasuratwong, Y.; Mongkolsomlit, S. 2006: Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus Journal of the Medical Association of Thailand 89(Suppl 1): S27-S36
Heng, B.Hoon.; Sun, Y.; Cheah, J.T.S.; Jong, M. 2010: The Singapore National Healthcare Group Diabetes Registry--descriptive epidemiology of type 2 diabetes mellitus Annals of the Academy of Medicine Singapore 39(5): 348-352
Farrell, C.; Moran, J. 2014: Comparison of comorbidities in patients with pre-diabetes to those with diabetes mellitus type 2 Irish Medical Journal 107(3): 72-74